GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matricelf Ltd (OTCPK:MTRLF) » Definitions » Asset Impairment Charge

Matricelf (Matricelf) Asset Impairment Charge : $0.00 Mil (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is Matricelf Asset Impairment Charge?

Matricelf's Asset Impairment Charge for the six months ended in . 20 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Matricelf Asset Impairment Charge Historical Data

The historical data trend for Matricelf's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Matricelf Asset Impairment Charge Chart

Matricelf Annual Data
Trend
Asset Impairment Charge

Matricelf Semi-Annual Data
Asset Impairment Charge

Matricelf Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Matricelf Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Matricelf's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Matricelf (Matricelf) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matricelf Ltd (OTCPK:MTRLF) » Definitions » Asset Impairment Charge
Comparable Companies
XTAE:CBI XTAE:CANF XTAE:BOLT XTAE:KDST XTAE:DNA XTAE:XTLB XTAE:PLNT XTAE:HDST-M XTAE:EVGN XTAE:GFC-M OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
MTLF:Israel
Address
Golda Meir 3, Ness Ziona, ISR, 6701838
Website
https://www.matricelf.com
Matricelf Ltd is engaged in research and development in the field of medicine and tissue engineering. It is a pioneering biotechnology company developing a platform for autologous matrix and cells implants for a wide range of medical conditions.

Matricelf (Matricelf) Headlines

From GuruFocus

Matricelf technology in treating paralysis due to chronic spinal cord injury in mice with the world's first 3D engineered neural tissue implant

By PRNewswire PRNewswire • 02-07-2022

Matricelf has reached a major milestone

By PRNewswire PRNewswire • 05-02-2022